CDK2 inhibitors
US11932648B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 2022 |
| Grant date | Mar 19, 2024 |
| Priority date | — |
| Expiry date | Jun 27, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a compound represented by structural Formula (I): or a pharmaceutically acceptable salt thereof useful for treating a cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.